CN102327643A - 一种用于骨组织再生的生物支架 - Google Patents
一种用于骨组织再生的生物支架 Download PDFInfo
- Publication number
- CN102327643A CN102327643A CN201110242507A CN201110242507A CN102327643A CN 102327643 A CN102327643 A CN 102327643A CN 201110242507 A CN201110242507 A CN 201110242507A CN 201110242507 A CN201110242507 A CN 201110242507A CN 102327643 A CN102327643 A CN 102327643A
- Authority
- CN
- China
- Prior art keywords
- solution
- chitosan
- chitosan polymer
- glycerol
- genipin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000988 bone and bone Anatomy 0.000 title abstract description 27
- 230000017423 tissue regeneration Effects 0.000 title abstract 2
- 229920001661 Chitosan Polymers 0.000 claims abstract description 100
- 229920000642 polymer Polymers 0.000 claims abstract description 68
- 239000000843 powder Substances 0.000 claims abstract description 30
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 18
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 17
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims abstract description 16
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000015110 jellies Nutrition 0.000 claims abstract description 13
- 239000008274 jelly Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 238000010382 chemical cross-linking Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 108010010803 Gelatin Proteins 0.000 claims description 8
- 229920000159 gelatin Polymers 0.000 claims description 8
- 239000008273 gelatin Substances 0.000 claims description 8
- 235000019322 gelatine Nutrition 0.000 claims description 8
- 235000011852 gelatine desserts Nutrition 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920000554 ionomer Polymers 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 10
- 238000004132 cross linking Methods 0.000 abstract description 5
- 239000003102 growth factor Substances 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000012567 medical material Substances 0.000 abstract description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 abstract 2
- 239000001488 sodium phosphate Substances 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 25
- 238000002474 experimental method Methods 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 10
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 7
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 238000000518 rheometry Methods 0.000 description 7
- 239000000017 hydrogel Substances 0.000 description 6
- 210000001185 bone marrow Anatomy 0.000 description 5
- 229940112869 bone morphogenetic protein Drugs 0.000 description 5
- 239000000084 colloidal system Substances 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 230000011164 ossification Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 101150061927 BMP2 gene Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 210000002536 stromal cell Anatomy 0.000 description 2
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000004663 osteoprogenitor cell Anatomy 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000037922 refractory disease Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110242507.4A CN102327643B (zh) | 2011-08-23 | 2011-08-23 | 一种用于骨组织再生的生物支架 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110242507.4A CN102327643B (zh) | 2011-08-23 | 2011-08-23 | 一种用于骨组织再生的生物支架 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102327643A true CN102327643A (zh) | 2012-01-25 |
CN102327643B CN102327643B (zh) | 2016-06-22 |
Family
ID=45479766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110242507.4A Expired - Fee Related CN102327643B (zh) | 2011-08-23 | 2011-08-23 | 一种用于骨组织再生的生物支架 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102327643B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104841014A (zh) * | 2015-05-19 | 2015-08-19 | 南方医科大学 | 一种载有普伐他汀钠的血管组织工程支架材料的制备方法 |
CN105920675A (zh) * | 2016-04-14 | 2016-09-07 | 苏州大学 | 一种制备生物功能化壳聚糖水凝胶的方法 |
CN111110926A (zh) * | 2020-02-11 | 2020-05-08 | 南通大学 | 一种用于消化道粘膜分层的可注射有色凝胶垫及其应用 |
CN113292743A (zh) * | 2021-05-21 | 2021-08-24 | 福州大学 | 一种可注射高耐压高强度抗冻京尼平交联明胶水凝胶及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1394655A (zh) * | 2002-07-10 | 2003-02-05 | 浙江大学 | 组织工程用胶原/壳聚糖多孔支架的制备方法 |
-
2011
- 2011-08-23 CN CN201110242507.4A patent/CN102327643B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1394655A (zh) * | 2002-07-10 | 2003-02-05 | 浙江大学 | 组织工程用胶原/壳聚糖多孔支架的制备方法 |
Non-Patent Citations (2)
Title |
---|
JOSÉ MOURA ET AL.: "In Situ Forming Chitosan Hydrogels Prepared via Ionic/Covalent Co-Cross-Linking", 《BIOMACROMOLECULES》, vol. 12, 20 July 2011 (2011-07-20), pages 3275 - 3284 * |
姚芳莲 等: "京尼平对壳聚糖及明胶的交联反应", 《天津大学学报》, vol. 40, no. 12, 31 December 2007 (2007-12-31), pages 1485 - 1489 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104841014A (zh) * | 2015-05-19 | 2015-08-19 | 南方医科大学 | 一种载有普伐他汀钠的血管组织工程支架材料的制备方法 |
CN105920675A (zh) * | 2016-04-14 | 2016-09-07 | 苏州大学 | 一种制备生物功能化壳聚糖水凝胶的方法 |
CN111110926A (zh) * | 2020-02-11 | 2020-05-08 | 南通大学 | 一种用于消化道粘膜分层的可注射有色凝胶垫及其应用 |
CN111110926B (zh) * | 2020-02-11 | 2022-04-01 | 南通大学 | 一种用于消化道粘膜分层的可注射有色凝胶垫及其应用 |
CN113292743A (zh) * | 2021-05-21 | 2021-08-24 | 福州大学 | 一种可注射高耐压高强度抗冻京尼平交联明胶水凝胶及其制备方法 |
CN113292743B (zh) * | 2021-05-21 | 2022-08-19 | 福州大学 | 一种可注射高耐压高强度抗冻京尼平交联明胶水凝胶及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102327643B (zh) | 2016-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xin et al. | Inorganic strengthened hydrogel membrane as regenerative periosteum | |
EP3532117B1 (en) | Preparation and applications of 3d bioprinting bioinks for repair of bone defects, based on cellulose nanofibrils hydrogels with natural or synthetic calcium phosphate particles | |
Khoshakhlagh et al. | Development and characterization of a bioglass/chitosan composite as an injectable bone substitute | |
Ma et al. | Modification of 3D printed PCL scaffolds by PVAc and HA to enhance cytocompatibility and osteogenesis | |
CN111097068B (zh) | 一种仿生的羟基磷灰石粉体/明胶/海藻酸钠复合3d打印支架及其制备方法 | |
CN110665063A (zh) | 3d生物打印墨水及其制备方法、组织工程支架及其制备方法 | |
WO2018078130A1 (en) | Preparation and applications of 3d bioprinting bioinks for repair of bone defects, based on cellulose nanofibrils hydrogels with natural or synthetic calcium phosphate particles | |
Zhao et al. | Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold | |
CN106999635A (zh) | 软骨修复用移植物支架及其制造方法 | |
Wu et al. | Development of a chitosan–polyglutamate based injectable polyelectrolyte complex scaffold | |
CN102294049B (zh) | 生物活性玻璃与壳聚糖复合骨修复材料及其制法和用途 | |
Nie et al. | Nano-hydroxyapatite mineralized silk fibroin porous scaffold for tooth extraction site preservation | |
CN105688274A (zh) | 一种聚己内酯/明胶电纺复合支架的制备工艺 | |
Pan et al. | Engineered macroporous hydrogel scaffolds via pickering emulsions stabilized by MgO nanoparticles promote bone regeneration | |
CN102399370B (zh) | 一种壳聚糖聚合物及其制备方法 | |
You et al. | Fabrication and osteogenesis of a porous nanohydroxyapatite/polyamide scaffold with an anisotropic architecture | |
CN112972760B (zh) | 一种负载内皮细胞外基质的3d打印骨缺损修复支架及其制备方法 | |
CN103007358B (zh) | 一种软骨组织工程纤维支架材料及其制备方法 | |
Raja et al. | Multifunctional calcium-deficient hydroxyl apatite–alginate core–shell-structured bone substitutes as cell and drug delivery vehicles for bone tissue regeneration | |
Cao et al. | A simple polysaccharide based injectable hydrogel compositing nano-hydroxyapatite for bone tissue engineering | |
CN102327643B (zh) | 一种用于骨组织再生的生物支架 | |
Mahmood et al. | 3-D nanocomposite scaffolds: Tissue engineering for bone reconstruction | |
Develioglu et al. | Evaluation of the long-term results of rat cranial bone repair using a particular xenograft | |
Li et al. | Minimally invasive bone augmentation through subperiosteal injectable hydroxylapatite/laponite/alginate nanocomposite hydrogels | |
Sun et al. | A novel gelatin/carboxymethyl chitosan/nano-hydroxyapatite/β-tricalcium phosphate biomimetic nanocomposite scaffold for bone tissue engineering applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LIN FENG TANG PEIFU LI HONGQIN Effective date: 20140226 |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140226 Address after: 100076 Beijing Fengtai District Donggaodi Wanyuan Sirirath 5 Building 3 unit 502 Applicant after: Zhao Wen Applicant after: Lin Feng Applicant after: Tang Peifu Applicant after: Li Hongqin Address before: 100076 Beijing city Fengtai District Donggaodi Wanyuan Sirirath 5 Building 3 unit 502 Applicant before: Zhao Wen |
|
TA01 | Transfer of patent application right | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160622 Termination date: 20190823 |
|
CF01 | Termination of patent right due to non-payment of annual fee |